Mar 28, 2024
Watch this pre-recorded session to learn about the future of intellectual property for cannabis and hemp products with rescheduling on the horizon. This webinar will feature a discussion with VLLP IP specialists regarding patent, IP and trademark protection, cannabis research, and what may change with potential federal marijuana rescheduling.
By Jason Adelstone
Mar 21, 2024
The International Narcotics Control Board (INCB) may be taking a more measured approach to cannabis. In their 2023 report, INCB used the word "may" when discussing potential inconsistencies between US state legalization and international treaties. This subtle shift in language suggests a more open-minded approach. This blog post explores the significance of this change in the report’s language and what it might mean for the future of global cannabis legalization.
By Jason Adelstone
Feb 27, 2024
Germany's recent enactment of a marijuana decriminalization bill marks a significant development in European drug policy. While falling short of full legalization, the new law allows for decriminalized possession, home cultivation, and participation in cannabis clubs. This blog post provides a concise overview of the new legislation, its potential impact, and its wider implications for the evolving European cannabis landscape.
By Jason Adelstone
Jan 30, 2024
On August 29, 2023, the Department of Health and Human Services (“HHS”) sent the Drug Enforcement Administration (“DEA”) its recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). Since then, the marijuana industry has waited in suspense for the DEA to make the final call as to what schedule marijuana will be placed. Read this Insights post that outlines the complex process of marijuana rescheduling in the US and outlines the key steps involved, from rule publication to review and final rule, emphasizing the critical role of stakeholder engagement in securing a Schedule III classification.
By Jason Adelstone
Dec 7, 2023
On October 27, 2023, the Ninth Circuit Court of Appeals, in Aggarwal v. DEA, held that the U.S. Drug Enforcement Agency (DEA) must reconsider its denial of a petition to transfer psilocybin, the active ingredient in “magic mushrooms” from Schedule I to Schedule II. Read this Insights post for more information about the Ninth Circuit Court’s order to reschedule psilocybin.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
Oct 4, 2023
Watch this special briefing where Vicente LLP leaders share insights on the impacts of the HHS recommendation to reschedule cannabis and outline the road ahead.
Jul 13, 2023
Join ACR for a Roundtable Discussion on SAFE banking in the cannabis industry, specifically focusing on the impact on small and minority-owned businesses. The webinar featuring Vicente attorney Elliot Choi will be held on Tuesday, July 25th, from 6:30 - 8 p.m. ET.
Apr 6, 2023
In this episode of Cannabis Minds, Jen Flanagan interviews her colleague Sahar Ayinehsazian who gives valuable advice for cannabis operators and applicants seeking banking services.
By Jason Adelstone
Mar 15, 2023
In its 2022 report, the International Narcotics Control Board (INCB) argues that legalizing the non-medical and non-scientific use of cannabis has failed to achieve the benefits to society that were intended through such legalization. In its attempt to deliver evidence of this failure, INCB instead provides ample evidence to the contrary—that legalization and regulation work. Read this insight for Vicente LLP’s response to the annual report of the INCB.
By Cassia Furman, Jason Adelstone
Feb 24, 2023
A bill passed in 2022 authorized California to enter into agreements with neighboring states allowing for interstate transfers between cannabis licensees, so long as the cannabis products don’t pass through a non-legal state. Could this be implemented? What are the risks?
Dec 27, 2022
In a CLE on January 12, 2023, Charles Alovisetti will offer advice on the legal and practical issues borrowers and lenders need to consider when documenting and funding a loan transaction secured by cannabis-related real estate
Dec 23, 2022
On January 7, 2023, the VS team will provide legal services at a drug conviction record sealing clinic in Denver, Colorado.
Oct 5, 2022
VS partners Charles Alovisetti and FL Gorman will discuss debtor-creditor rights pertaining to cannabis at NYSBA’s virtual CRE program on October 6
By Charles Alovisetti, Elliot Y. Choi, and Sahar Ayinehsazian
Sep 29, 2022
Charles Alovisetti, Elliot Y. Choi, and Sahar Ayinehsazian write for the Bloomberg Law, reflecting on the challenges and journey of raising private capital in the cannabis industry
Sep 21, 2022
VS partners Sahar Ayinehsazian and Jerrico Perez will be on a LIVE cannabis banking compliance NHCC Legal Committee seminar on September 28!
Jul 29, 2022
Sahar Ayinehsazian will be speaking at the 2022 PBC Conference on September 8, 2022 to discuss financial investing in the cannabis business space
By Jason Adelstone
Apr 27, 2022
A recent paper by Kenzi Riboulet-Zemouli argues that the 1961 Single Convention on Narcotic Drugs already allows for the regulation of Non-Medical cannabis. This premise, unfortunately, is just incorrect.
Aug 18, 2021
VS director of economics and research, Andrew Livingston, joined The Green Rush Live to discuss the Federal CAO Act and more.
Jul 22, 2021
VS's Jason Adelstone, Catie Wightman and Genevieve Meehan will participate in a free expungement clinic to be held on July 31, 2021 in Denver.
By Vicente Sederberg LLP
May 24, 2021
Read the memo VS delivered to the International Narcotics Control Board, which gives draft guidelines on control requirements for medical and scientific cannabis and discusses the implications and important issues for consideration.
By Corey Cox, Caitlin Wightman
May 24, 2021
The Colorado government has enacted several programs aimed at helping businesses and workers adversely impacted by the novel coronavirus (COVID-19).
By Charles Alovisetti, Cassia Furman
Apr 23, 2021
To many in the cannabis industry, REIT is not a common acronym. Yet, as cannabis businesses seek ways to raise funds, REITs are coming up in more and more conversations.
By Andrea A. Golan, Michelle Bodian
Jan 28, 2021
Cannabis businesses are not eligible for relief under any of the federal COVID-19 aid packages, but members of Congress and industry groups are making significant efforts to include cannabis businesses in federal aid.
By Jerrico Perez and Jason Adelstone
Oct 29, 2020
On November 3, 2020, Arizona voters will again vote to legalize an adult-use marijuana program, four years after rejecting a similar initiative.
Sep 3, 2020
Sahar will present "Curbing Cannabis Cash" at DRI's Cannabis Law Virtual Seminar on September 17, 2020.
Aug 13, 2020
This session explores the complexity of mergers and acquisitions and how to optimize taxes to free cash flow for your cannabis business.
Jul 9, 2020
VS attorney Sahar Ayinehsazian discusses cannabis industry banking and the many reasons why there is a demand for cannabis legal advice during the COVID-19 pandemic on CSE's Hashtag Finance podcast.
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian, Corey Cox
May 5, 2020
The continuing growth of the cannabis and hemp industries has given rise to the need for specifically tailored due diligence.
By Meg Nash, David Gately
Apr 30, 2020
The Massachusetts government has enacted several programs aimed at helping businesses and workers adversely impacted by the novel coronavirus (COVID-19).
By Andrea A. Golan
Apr 24, 2020
While cannabis businesses are not currently eligible for many federal relief programs established in response to COVID-19, they may be eligible for this form of federal relief.
By Andrea A. Golan and Kelsey Middleton
Apr 22, 2020
By Charles Alovisetti, Phil Silverman, Jason Adelstone
Apr 17, 2020
Bankruptcy law provides advantages for financially distressed companies to restructure debt while continuing to operate. Without access to U.S. Bankruptcy Code protections, marijuana companies must turn to out-of-court restructurings and state law insolvency proceedings.
Mar 6, 2020
Learn about cannabis industry best practices for indirect taxes and 280E by watching this webinar replay with tax firm Ryan LLC and attorney Jordan Wellington.
Dec 13, 2019
Join VS and the tax experts at Ryan LLC for a live discussion on cannabis industry taxation, including 280E and best practices for indirect tax issues in the cannabis industry.
By Sahar Ayinehsazian, Associate Attorney
Dec 12, 2019
On December 3, 2019, a group of federal financial regulators took an important step to enable hemp operators to access banking services by publishing hemp banking guidance.
Oct 29, 2019
Watch Vicente Sederberg LLP attorney Sahar Ayinehsazian and HUB International Insurance Services in this on-demand webinar about investments in the cannabis industry.
By Charles S. Alovisetti, Partner
Oct 7, 2019
In addition to federal securities laws, each state and territory has its own securities laws, often referred to as blue sky laws. Cannabis company compliance with these rules may be more important due to heightened regulatory scrutiny.
By Charles S. Alovisetti, Partner; Phil Silverman, Counsel; Jason Adelstone, Law Clerk
Sep 27, 2019
One of the many issues arising out of the tension between state and federal law in the cannabis industry is whether cannabis companies can access the protections of federal bankruptcy law.
Aug 28, 2019
WeedWeek hosts Alex Halperin and Donnell Alexander recently invited VS attorney Sahar Ayinehsazian to discuss cannabis banking on their weekly podcast.
